M
MDT
MDTUnverified7 segments tracked|9 years of data|Annual (10-K)
Total Revenue
$54.4B4.4%
FY2025
Operating Segments
7Active segments
Blended Margin
23.1%Operating margin
Highest Margin
84.1%Neuroscience Group
Segment Shift
Neuroscience Group has grown from 0.0% to 9.1% of total revenue since FY2015, with 84.1% operating margins. Meanwhile, Diabetes Group is the fastest growing at +10.7% YoY.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2025
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Total Reportables | $33.5B | $0 | 0.0% | 61.6% | +4.2% |
| Medical Surgical | $6.5B | $3.0B | 46.8% | 11.9% | -0.2% |
| Cardiovascular | $6.4B | $4.8B | 75.1% | 11.8% | +6.6% |
| Neuroscience Group | $5.0B | $4.2B | 84.1% | 9.1% | +4.6% |
| Diabetes Group | $2.8B | $491M | 17.8% | 5.1% | +10.7% |
| All Others | $137M | $0 | 0.0% | 0.3% | -38.0% |
| Other | $137M | $49M | 35.8% | 0.3% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free